In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens
- 1 May 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (5) , 1260-1263
- https://doi.org/10.1128/aac.43.5.1260
Abstract
The in vitro activity of Syn-2869 was compared with that of amphotericin B and itraconazole. MICs for 100 isolates of pathogenic molds belonging to 12 species were determined by a broth microdilution adaptation of the method recommended by the National Committee for Clinical Laboratory Standards. Syn-2869 and itraconazole showed comparable, good activity against the dematiaceous molds Cladophialophora bantiana , Cladophialophora carrionii , Exophiala dermatitidis , Fonsecaea pedrosoi , Phialophora parasitica , and Ramichloridium mackenziei . Neither of the azole agents was active against the hyaline molds Fusarium solani , Scedosporium prolificans , and Scopulariopsis brevicaulis , but both were more active than amphotericin B against Scedosporium apiospermum . The MICs of the three agents were comparable for the mucoraceous mold Absidia corymbifera , but Syn-2869 appeared to be the least active against the dimorphic mold Sporothrix schenckii . Our results suggest that Syn-2869 could be effective against a range of mold infections in humans.Keywords
This publication has 18 references indexed in Scilit:
- Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infectionJournal of Antimicrobial Chemotherapy, 1997
- Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the LiteratureMedicine, 1997
- Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida InfectionsClinical Infectious Diseases, 1997
- Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experienceEuropean Journal of Haematology, 1996
- The Safety and Efficacy of Amphotericin B Colloidal Dispersion in the Treatment of Invasive MycosesClinical Infectious Diseases, 1995
- Emerging Fungal Pathogens in Immunocompromised Patients: Classification, Diagnosis, and ManagementClinical Infectious Diseases, 1993
- Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and ReviewClinical Infectious Diseases, 1992
- Disseminated Infection with Fusarium in Recipients of Bone Marrow TransplantsClinical Infectious Diseases, 1991
- Itraconazole treatment of phaeohyphomycosisJournal of the American Academy of Dermatology, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990